Developing an integrated model of relevant sources of information – preclinical data, proprietary pharmacokinetic and pharmacodynamic (PK/PD) data, and public-literature data – plays an increasingly critical role in designing successful trials. Our clients have gained important insights from predictive drug-disease and trial simulations that are the basis for more informative and less costly trial designs – while leading to more productive interactions with regulatory bodies.
We work closely with client teams to increase our clients’ analytic capacity. Close collaboration also ensures that new drug-development insights and their process implications are quickly understood and incorporated. Our clients come away with a model they own, understand, and can stand behind.
Contact us today to learn more about our PK/PD modeling and clinical trial simulation services.
Check out our case studies.